In this article, we explore the experiences of sickle cell patients in emergency care and the ways they can advocate for themselves ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...

Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes ...

Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role ...

We detected ANA in 5/9 of the SLE patients and none of the 7 HD sera. The same subjects with positive ANA in the serum, also had positive ANA in the BM supernatant as shown in Figures 9B, C. Of note, ...

Lin et al. reviewed the issue of SLE disease activity assessment both in clinical practice and research. It was initially acknowledged that activity indices are important for routine treat -to -target ...

As I turned back, thinking that I had to live like Tom Hanks in The Terminal before my next flight, I searched on Red Note. Thanks to multiple posts by people who had been in the exact same ...

Systemic Lupus Erythematosus (SLE)-lupus for short-is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body's own tissues.